Anagrelide
- Product NDC
- 70954-879
- 11-digit product format
- 709540879
- Labeler code
- 70954
- Product ID
- 70954-879_56b3959d-4b6b-413f-b753-9d4c20c07466
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Anagrelide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA076811
- Marketing category
- ANDA
- Marketing start
- 2025-11-06
- Substance
- ANAGRELIDE HYDROCHLORIDE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anagrelide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ANAGRELIDE HYDROCHLORIDE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YTM763Y5C8 |
| Rxcui | 597850, 597852 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70954-879-10 | Anagrelide | 100 in 1 BOTTLE | CAPSULE | 100 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70954-879-10 | 70954087910 | 100 CAPSULE in 1 BOTTLE (70954-879-10) | 100 capsule | 2025-11-06 | No | No | Historical |